The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Intraovarian Control of Early Folliculogenesis
Open accessAbstract
Although hormonal regulation of ovarian follicle development has been extensively investigated, most studies concentrate on the development of early antral follicles to the preovulatory stage, leading to the successful use of exogenous FSH for infertility treatment. Accumulating data indicate that preantral follicles are under stringent regulation by FSH and local intraovarian factors, thus providing the possibility to develop new therapeutic approaches. Granulosa cell-derived C-type natriuretic factor not only suppresses the final maturation of oocytes to undergo germinal vesicle breakdown before ovulation but also promotes preantral and antral follicle growth. In addition, several oocyte- and granulosa cell-derived factors stimulate preantral follicle growth by acting through wingless, receptor tyrosine kinase, receptor serine kinase, and other signaling pathways. In contrast, the ovarian Hippo signaling pathway constrains follicle growth and disruption of Hippo signaling promotes the secretion of downstream CCN growth factors capable of promoting follicle growth. Although the exact hormonal factors involved in primordial follicle activation has yet to be elucidated, the protein kinase B (AKT) and mammalian target of rapamycin signaling pathways are important for the activation of dormant primordial follicles. Hippo signaling disruption after ovarian fragmentation, combined with treating ovarian fragments with phosphatase and tensin homolog (PTEN) inhibitors and phosphoinositide-3-kinase stimulators to augment AKT signaling, promote the growth of preantral follicles in patients with primary ovarian insufficiency, leading to a new infertility intervention for such patients. Elucidation of intraovarian mechanisms underlying early folliculogenesis may allow the development of novel therapeutic strategies for patients diagnosed with primary ovarian insufficiency, polycystic ovary syndrome, and poor ovarian response to FSH stimulation, as well as for infertile women of advanced reproductive age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–221 of 221
Oocyte‐derived R‐spondin2 promotes ovarian follicle development
Cheng, Y., Kawamura, K., Takae, S., Deguchi, M., Yang, Q., Kuo, C. J., & Hsueh, A. J. W. (2013) · The FASEB Journal · doi:10.1096/fj.12-223412 · Cited by 64
Self-citationHendriks, M. L., Ket, J. C. F., Hompes, P. G. A., Homburg, R., & Lambalk, C. B. (2007) · Human Reproduction Update · doi:10.1093/humupd/dml058 · Cited by 63
Modi, D. N., Bhartiya, D., & Puri, C. P. (2006) · Reproduction · doi:10.1530/rep.1.01178 · Cited by 62
Zhang, T., Liang, W., Fang, M., Yu, J., Ni, Y., & Li, Z. (2013) · Gene · doi:10.1016/j.gene.2013.04.040 · Cited by 47
Aberrant GDF9 Expression and Activation Are Associated With Common Human Ovarian Disorders
Simpson, C. M., Robertson, D. M., Al-Musawi, S. L., Heath, D. A., McNatty, K. P., Ritter, L. J., Mottershead, D. G., Gilchrist, R. B., Harrison, C. A., & Stanton, P. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3949 · Cited by 47
Should androgen supplementation be used for poor ovarian response in IVF?
Sunkara, S. K., Coomarasamy, A., Arlt, W., & Bhattacharya, S. (2012) · Human Reproduction · doi:10.1093/humrep/der464 · Cited by 47
Roberts, A. E., Arbogast, L. K., Friedman, C. I., Cohn, D. E., Kaumaya, P. T. P., & Danforth, D. R. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.106.050880 · Cited by 45
Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles
Zangmo, R., Singh, N., Kumar, S., Vanamail, P., & Tiwari, A. (2014) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2014.01.019 · Cited by 42
Zhao, H., & Chen, Z. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat040 · Cited by 36
Update in Hyper- and Hypogonadotropic Amenorrhea
Santoro, N. F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1419 · Cited by 34
In vivo evidence of role of bone morphogenetic protein-4 in the mouse ovary
Tanwar, P. S., O’Shea, T. M., & McFarlane, J. R. (2007) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2007.04.015 · Cited by 33
Trends and Outcomes for Donor Oocyte Cycles in the United States, 2000–2010
Kawwass, J. F., Monsour, M., Crawford, S. B., et al. (2014) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000446903.17513.fd · Cited by 33
Ovarian Kaleidoscope Database: Ten Years and Beyond1
Hsueh, A. J. W., & Rauch, R. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.112.099127 · Cited by 32
Self-citationHuang, L., Wang, Z.-B., Jiang, Z.-Z., Hu, M., Lin, F., Zhang, Q.-H., Luo, Y.-B., Hou, Y., Zhao, Y. X., Fan, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054052 · Cited by 31
Asymmetric limb malformations in a new transgene insertional mutant, footless
Bell, S. M., Schreiner, C. M., Hess, K. A., Anderson, K. P., & Scott, W. J. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(03)00021-2 · Cited by 31
Louwers, Y. V., de Jong, F. H., van Herwaarden, N. A. A., Stolk, L., Fauser, B. C. J. M., Uitterlinden, A. G., & Laven, J. S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1976 · Cited by 27
Self-citationPolymorphic CAG repeat in the androgen receptor gene in polycystic ovary syndrome patients
Wang, Y. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.789 · Cited by 27
The physiology and clinical utility of anti-Müllerian hormone in women
Dewailly, D., Andersen, C. Y., Balen, A. H., Broekmans, F. J., Dilaver, N., Fanchin, R. R. F., Griesinger, G., Kelsey, T., Marca, A. L., Lambalk, C. B., et al. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu043 · Cited by 26
Chaves, R. N., Lima-Verde, I. B., Celestino, J. J. H., Duarte, A. B. G., Alves, A. M. C. V., Matos, M. H. T., Campello, C. C., Name, K. P. O., Báo, S. N., Junior, J. B., et al. (2010) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2010.06.006 · Cited by 23
Pure Strain Mice Born to Hybrid Mothers Following Ovarian Transplantation
Russell, W. L., & Hurst, J. G. (1945) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.31.9.267 · Cited by 21
Organization of non-muscle myosin during early murine embryonic differentiation
Slager, H. G., Good, M. J., Schaart, G., Groenewoud, J. S., & Mummery, C. L. (1992) · Differentiation · doi:10.1111/j.1432-0436.1992.tb00485.x · Cited by 20
Cited by
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Day, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007813 · Cited by 619
Self-citationDewailly, D., Robin, G., Peigne, M., Decanter, C., Pigny, P., & Catteau-Jonard, S. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw027 · Cited by 526
Wagner, M., Yoshihara, M., Douagi, I., Damdimopoulos, A., Panula, S., Petropoulos, S., Lu, H., Pettersson, K., Palm, K., Katayama, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14936-3 · Cited by 370
Cell Origins of High-Grade Serous Ovarian Cancer
Kim, J., Park, E., Kim, O., Schilder, J., Coffey, D., Cho, C.-H., & Bast, R. (2018) · Cancers · doi:10.3390/cancers10110433 · Cited by 264
Metadata
- Authors
- Hsueh, A. J. W., Kawamura, K., Cheng, Y., & Fauser, B. C. J. M.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2015-02-01
- Volume
- 36
- Issue
- 1
- Pages
- 1-24
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2068364416
- Cited by
- 702
- References
- 221
- FWCI
- 26.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.